New nerve blocks may ease pain after heart surgery

NCT ID NCT06793436

Completed Symptom relief Sponsor: Yuzuncu Yil University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Aug 07, 2026 · Updated 3 times

Summary

This study tested two types of nerve blocks (SAP and PECS II) to see if they could reduce pain after coronary artery bypass grafting. 243 adults received one of the blocks or standard care. Researchers measured pain scores, opioid use, and recovery times. The goal was to find a better way to manage post-surgery pain.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bupivacaine
What this could lead to: If effective, these nerve blocks could become a standard way to reduce pain and opioid use after heart bypass surgery.
What could go wrong: This is a completed trial, but the results are not yet widely confirmed. The blocks may not work for everyone and carry small risks like bleeding or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY BYPASS GRAFTING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY BYPASS GRAFTING POSTOPERATIVE PAIN

Contacts and locations

Locations

Van Yuzuncu Yil University Faculty of Medicine Department of anesthesiology and reanimation

Van, Tuşba, 65080, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.